Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers.

Abdollahzade, Aref; Rahimi, Hoda; Yaghoobi, Elnaz; Ramezani, Mohammad; Alibolandi, Mona; Abnous, Khalil; Taghdisi, Seyed Mohammad.

Afiliação

Abdollahzade A; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Rahimi H; School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Yaghoobi E; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Ramezani M; Department of Chemistry and Biomolecular Sciences, University of Ottawa, 10 Marie-Curie, Ottawa, ON K1N 6N5, Canada.
Alibolandi M; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Abnous K; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Taghdisi SM; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Iran J Basic Med Sci ; 26(10): 1177-1187, 2023.

Article em En | MEDLINE | ID: mdl-37736517